SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently seeing significant retail and institutional focus as investors await topline Phase 3 IZAR-1 data, which remains a critical catalyst for the company's multi-indication thesis. The community is actively debating the stock's potential for a best-in-class profile in psoriatic arthritis versus concerns over trial timelines and competitive pressures in the immunology space.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as investors debate the impact of a proposed $15 billion common stock offering, which has sparked concerns over dilution despite management framing the move as necessary for capital expenditures and AI-driven growth. The stock remains a focal point for the community, with active discussions split between those viewing the price volatility as a manipulation-driven buying opportunity and those frustrated by the lack of specific filing details.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors focus on the upcoming Phase 2 clinical trial readout for its menopause drug, ABCL635, while tracking recent strategic board appointments and major pharmaceutical partnerships that bolster the company's platform validation. The community is actively debating the stock's potential for a significant re-rating against the backdrop of high short interest and anticipation of positive clinical data.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is capturing significant market attention following a high-profile collaboration with Boeing and an acquisition strategy aimed at accelerating its physical AI and aerospace defense capabilities. Investors are closely monitoring upcoming earnings and the potential impact of these strategic partnerships on the company's certification progress and operational trajectory.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors focus on the company's strategic pivot toward AI infrastructure following its acquisition of Northern Data and its significant compute capacity. The community is actively debating the stock's potential for a short squeeze given the high short interest, while awaiting formal guidance and earnings results to validate its growth narrative as a cloud and AI player.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is currently a focal point for investors as the community debates whether the stock represents a deep-value opportunity following a sharp pullback or a long-term casualty of AI-driven disruption in the SaaS sector. Bulls are highlighting the company's strong cash position and growth metrics while pointing to potential short-squeeze activity, while bears remain skeptical about its competitive positioning against emerging AI-native alternatives.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is seeing heightened activity as the CEO attends high-profile government roundtables on domestic critical minerals, fueling community speculation about upcoming production orders and strategic government support. Investors are closely monitoring the stock ahead of imminent earnings and recent institutional accumulation, despite broader sector volatility and short interest that keeps sentiment intensely focused on potential squeeze catalysts.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is in the spotlight as investors digest a quarterly earnings beat and a significant new share repurchase program while navigating the implications of a planned IPO for its North American assets. Market sentiment is heavily influenced by the stock's role as a leveraged play on high gold prices and ongoing community interest in how the company will balance capital returns against potential expansion in the copper sector.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals is capturing market attention as analysts highlight the growth potential of its expanding non-CF pipeline, including recent kidney franchise progress and its foray into Type 1 diabetes. Community discussions remain focused on the company's long-term commercial momentum and the strategic importance of its recent M&A activity as it shifts beyond its core cystic fibrosis franchise.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in Japan, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is currently at the center of investor focus due to active takeover speculation involving GameStop and Ryan Cohen, which continues to drive heated debate regarding potential synergies and the board's resistance. Community discussions remain polarized, with many retail investors closely watching for institutional filings and price action that could signal a breakthrough in the hostile acquisition attempt.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PureTech Health (LON:PRTC) Shares Down 9.2% - Time to Sell?

PureTech Health (LON:PRTC) Trading Down 9.2% - What's Next...

PureTech Health H2 Earnings Call Highlights

PureTech Health (NASDAQ:PRTC) used its annual results call to outline a refined operating strategy centered on a leaner corporate structure, earlier formation of "founded entities," and an increased emphasis on returning capital to shareholders when significant inflows occur.

Chief Executive Office...

PureTech Health (NASDAQ:PRTC) Posts Quarterly Earnings Results, Beats Estimates By $0.59 EPS

PureTech Health (NASDAQ:PRTC - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($1.35) EPS for the quarter, topping analysts' consensus estimates of ($1.94...

PureTech Announces Annual Results for Year Ended December 31, 2025

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company) today announces its results for the year ended December 31, 2025, as well as its cash balance as of the first quarter ended...

PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today...

PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, notes...

PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory (R/R) High-Risk (HR) Myelodysplastic Syndrome (MDS) and R/R Acute Myeloid Leukemia (AML)

PureTech Health (PRTC) Expected to Announce Earnings on Wednesday

PureTech Health (NASDAQ:PRTC) will be releasing its H2 2025 earnings before the market opens on Wednesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-29-puretech-health-plc-stock...

PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Up 30.8% in March

PureTech Health PLC Sponsored ADR (NASDAQ:PRTC - Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totaling 14,823 shares, a...

PureTech Health: Notice of Results

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company') plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2025, on Wednesday...

PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others. The Internal segment focuses on immunological, fibrotic, and lymphatic system mechanisms. The Controlled Founded Entities segment is composed of the group’s subsidiaries that are currently consolidated operational subsidiaries that either have or have plans to hire independent management teams and currently have already raised, or are currently in the process of raising, third-party dilutive capital. The Non-Controlled Founded Entities segment includes companies wherein the group no longer holds majority voting control as a shareholder and no longer has the right to elect a majority of the members of the subsidiaries’ Board of Directors. The Parent Company and Other segment represents activities that are not directly attributable to the operating segments, such as the activities of the parent, corporate support functions and certain research and development support functions that are not directly attributable to a strategic business segment as well as the elimination of intercompany transactions. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.

PureTech Health Plc - ADR

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

PRTCPuretech Health

Fundamentals

Connect Stocktwits to ChatGPT

Latest PRTC News